中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2014年
25期
81-85,90
,共6页
张济周%邵琪琦%白微%黄兆明%周晨%陶玉
張濟週%邵琪琦%白微%黃兆明%週晨%陶玉
장제주%소기기%백미%황조명%주신%도옥
三七总皂苷%癌性贫血%促红细胞生成素%调节作用
三七總皂苷%癌性貧血%促紅細胞生成素%調節作用
삼칠총조감%암성빈혈%촉홍세포생성소%조절작용
Panax notoginseng saponins%Anemia of cancer%Erythropoietin%Regulation effect
目的利用三七总皂苷治疗癌性贫血患者,观察患者治疗后体内促红细胞生成素(EPO)的变化,判断三七总皂苷对癌性贫血患者EPO 的调节作用。方法将浙江中医药大学附属温州市中医院2012年2月-2014年1月收治的癌性贫血患者随机分成正常对照组尧三七总皂苷治疗组、力蜚能治疗组、益比奥治疗组。运用酶联免疫法及临床常规检查,测定各组患者每周内EPO 浓度变化,并用统计学方法加以分析。结果三七总皂苷治疗组对 EPO 有正向调节作用,与正常对照组、力蜚能治疗组比较,差异有统计学意义(P<0.05);但与益比奥治疗组比较,差异无统计学意义(P>0.05)。结论三七总皂苷可使癌性贫血患者体内EPO 升高,对癌性贫血患者EPO 有正向调节作用,可应用于临床癌性贫血患者的治疗。
目的利用三七總皂苷治療癌性貧血患者,觀察患者治療後體內促紅細胞生成素(EPO)的變化,判斷三七總皂苷對癌性貧血患者EPO 的調節作用。方法將浙江中醫藥大學附屬溫州市中醫院2012年2月-2014年1月收治的癌性貧血患者隨機分成正常對照組堯三七總皂苷治療組、力蜚能治療組、益比奧治療組。運用酶聯免疫法及臨床常規檢查,測定各組患者每週內EPO 濃度變化,併用統計學方法加以分析。結果三七總皂苷治療組對 EPO 有正嚮調節作用,與正常對照組、力蜚能治療組比較,差異有統計學意義(P<0.05);但與益比奧治療組比較,差異無統計學意義(P>0.05)。結論三七總皂苷可使癌性貧血患者體內EPO 升高,對癌性貧血患者EPO 有正嚮調節作用,可應用于臨床癌性貧血患者的治療。
목적이용삼칠총조감치료암성빈혈환자,관찰환자치료후체내촉홍세포생성소(EPO)적변화,판단삼칠총조감대암성빈혈환자EPO 적조절작용。방법장절강중의약대학부속온주시중의원2012년2월-2014년1월수치적암성빈혈환자수궤분성정상대조조요삼칠총조감치료조、력비능치료조、익비오치료조。운용매련면역법급림상상규검사,측정각조환자매주내EPO 농도변화,병용통계학방법가이분석。결과삼칠총조감치료조대 EPO 유정향조절작용,여정상대조조、력비능치료조비교,차이유통계학의의(P<0.05);단여익비오치료조비교,차이무통계학의의(P>0.05)。결론삼칠총조감가사암성빈혈환자체내EPO 승고,대암성빈혈환자EPO 유정향조절작용,가응용우림상암성빈혈환자적치료。
Objective To observe the changes in erythropoietin (EPO) after using panax notoginseng saponins (PNS) in treatment of patients with anemia of cancer, and then to judge the regulating effect of PNS to EPO. Methods The pa- tients with anemia of cancer admitted to Wenzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chi- nese Medical University from February 2012 to January 2014 were randomly divided into normal control group, PNS treatment group, Lifeineng treatment group, Yibiao treatment group. The concentration changes of EPO within each week of every group were determined by using enzyme-linked immunosorbent assay and clinical routine examination, and the dates was analyzed by statistical methods. Results PNS treatment group had a positive effect on the regulation of EPO. With the normal control group and Lifeineng treatment group compared, there was a statistical significance (P <0.05). But compared to Yibiao treatment group, there was no significant difference (P <0.05). Conclusion The exper- imental results show that PNS can increase the EPO in patients with anemia of cancer, and has a positive moderating effect on the EPO, it can treat the patients with clinical anemia of cancer.